Condensed Parent Company Information (Tables)
|
12 Months Ended |
Feb. 28, 2026 |
|---|
| Condensed Financial Information Disclosure [Abstract] |
|
| Schedule of Condensed Balance Sheets |
a. Condensed Balance Sheets
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
As of |
|
|
|
February 28,
2025 |
|
|
February 28,
2026 |
|
|
|
RMB |
|
|
RMB |
|
|
USD |
|
Current assets |
|
|
|
|
|
|
|
|
|
Cash and cash equivalents |
|
|
102,743 |
|
|
|
15,357 |
|
|
|
2,239 |
|
Short-term investments under fair value |
|
|
37,953 |
|
|
|
70,256 |
|
|
|
10,245 |
|
Long-term investments under fair value, current |
|
|
3,584 |
|
|
|
6,952 |
|
|
|
1,014 |
|
Amounts due from subsidiaries and consolidated VIEs |
|
|
1,460 |
|
|
|
1,409 |
|
|
|
205 |
|
Other current assets |
|
|
2,858 |
|
|
|
1,092 |
|
|
|
160 |
|
Total current assets |
|
|
148,598 |
|
|
|
95,066 |
|
|
|
13,863 |
|
Non-current assets |
|
|
|
|
|
|
|
|
|
Restricted cash |
|
|
127,449 |
|
|
|
130,363 |
|
|
|
19,009 |
|
Long-term investments under fair value, non-current |
|
|
99,571 |
|
|
|
143,886 |
|
|
|
20,981 |
|
Investments in subsidiaries and consolidated VIEs |
|
|
117,724 |
|
|
|
137,974 |
|
|
|
20,119 |
|
Total non-current assets |
|
|
344,744 |
|
|
|
412,223 |
|
|
|
60,109 |
|
Total assets |
|
|
493,342 |
|
|
|
507,289 |
|
|
|
73,972 |
|
Accrued expenses and other current liabilities |
|
|
1,043 |
|
|
|
653 |
|
|
|
96 |
|
Amounts due to subsidiaries and consolidated VIEs |
|
|
36,432 |
|
|
|
31,799 |
|
|
|
4,637 |
|
Other liabilities |
|
|
1,256 |
|
|
|
1,208 |
|
|
|
177 |
|
Total liabilities |
|
|
38,731 |
|
|
|
33,660 |
|
|
|
4,910 |
|
Ordinary Shares (US$0.0001 par value; 500,000,000 shares authorized, 22,600,576 and 22,614,376 shares issued and outstanding as of February 28, 2025 and 2026, respectively) |
|
|
15 |
|
|
|
15 |
|
|
|
2 |
|
Additional paid-in capital |
|
|
747,376 |
|
|
|
749,105 |
|
|
|
109,232 |
|
Treasury shares (2,363,567 and 2,363,567 shares as of February 28, 2025 and 2026, respectively) |
|
|
(45,115 |
) |
|
|
(45,115 |
) |
|
|
(6,579 |
) |
Accumulated deficit |
|
|
(276,538 |
) |
|
|
(245,751 |
) |
|
|
(35,835 |
) |
Accumulated other comprehensive income |
|
|
28,873 |
|
|
|
15,375 |
|
|
|
2,242 |
|
Total equity |
|
|
454,611 |
|
|
|
473,629 |
|
|
|
69,062 |
|
Total liabilities and equity |
|
|
493,342 |
|
|
|
507,289 |
|
|
|
73,972 |
|
|
| Schedule of Condensed Statements of Operations and Comprehensive Income |
b. Condensed Statements of Operations and Comprehensive Income
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
For the Year Ended |
|
|
|
February 29, |
|
|
February 28, |
|
|
February 28, |
|
|
|
2024 |
|
|
2025 |
|
|
2026 |
|
|
|
RMB |
|
|
RMB |
|
|
RMB |
|
|
USD |
|
Operating expenses |
|
|
(6,085 |
) |
|
|
(2,209 |
) |
|
|
(4,822 |
) |
|
|
(703 |
) |
Interest income, net |
|
|
6,518 |
|
|
|
15,712 |
|
|
|
7,535 |
|
|
|
1,099 |
|
Realized gain (loss) in investments |
|
|
3,207 |
|
|
|
(3,062 |
) |
|
|
3,938 |
|
|
|
574 |
|
Unrealized holding gain in investments |
|
|
3,910 |
|
|
|
2,022 |
|
|
|
2,438 |
|
|
|
356 |
|
Other income (expenses), net |
|
|
8 |
|
|
|
62 |
|
|
|
(15 |
) |
|
|
(2 |
) |
(Loss) income from investments in subsidiaries, VIEs and VIEs’ subsidiaries |
|
|
(2,597 |
) |
|
|
(11,724 |
) |
|
|
21,713 |
|
|
|
3,163 |
|
Income before income taxes |
|
|
4,961 |
|
|
|
801 |
|
|
|
30,787 |
|
|
|
4,487 |
|
Income tax (expense) benefit |
|
|
— |
|
|
|
— |
|
|
|
— |
|
|
|
— |
|
Net income |
|
|
4,961 |
|
|
|
801 |
|
|
|
30,787 |
|
|
|
4,487 |
|
Foreign currency translation adjustments |
|
|
9,347 |
|
|
|
3,768 |
|
|
|
(13,498 |
) |
|
|
(1,968 |
) |
Comprehensive income |
|
|
14,308 |
|
|
|
4,569 |
|
|
|
17,289 |
|
|
|
2,519 |
|
|
| Schedule of Condensed Statements of Cash Flows |
c. Condensed Statements of Cash Flows
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
For the Year Ended |
|
|
|
February 29, |
|
|
February 28, |
|
|
February 28, |
|
|
|
2024 |
|
|
2025 |
|
|
2026 |
|
|
|
RMB |
|
|
RMB |
|
|
RMB |
|
|
USD |
|
Net cash provided by operating activities |
|
|
931 |
|
|
|
8,955 |
|
|
|
9,058 |
|
|
|
1,321 |
|
Purchases of short-term investments under fair value |
|
|
(103,145 |
) |
|
|
(34,337 |
) |
|
|
(71,494 |
) |
|
|
(10,425 |
) |
Purchases of long-term investments under fair value |
|
|
(93,280 |
) |
|
|
(85,645 |
) |
|
|
(140,244 |
) |
|
|
(20,450 |
) |
Proceeds from maturity of investments |
|
|
327,495 |
|
|
|
174,123 |
|
|
|
125,275 |
|
|
|
18,267 |
|
Investments in consolidated subsidiaries |
|
|
— |
|
|
|
— |
|
|
|
(3,484 |
) |
|
|
(508 |
) |
Net cash provided by (used in) investing activities |
|
|
131,070 |
|
|
|
54,141 |
|
|
|
(89,947 |
) |
|
|
(13,116 |
) |
Proceeds from related parties loans |
|
|
1,287 |
|
|
— |
|
|
|
— |
|
|
|
— |
|
Repayment to related parties loans |
|
|
1 |
|
|
— |
|
|
|
— |
|
|
|
— |
|
Repurchase of ordinary shares |
|
|
(159 |
) |
|
— |
|
|
|
— |
|
|
|
— |
|
Net proceeds from option exercised |
|
|
— |
|
|
|
4,831 |
|
|
|
78 |
|
|
|
11 |
|
Dividends payment |
|
|
— |
|
|
|
(34,887 |
) |
|
|
— |
|
|
|
— |
|
Net cash provided by (used in) financing activities |
|
|
1,129 |
|
|
|
(30,056 |
) |
|
|
78 |
|
|
|
11 |
|
Effect of exchange rate changes |
|
|
(4,117 |
) |
|
|
2,152 |
|
|
|
(3,661 |
) |
|
|
(534 |
) |
Net increase (decrease) in cash and cash equivalents and restricted cash |
|
|
129,013 |
|
|
|
35,192 |
|
|
|
(84,472 |
) |
|
|
(12,318 |
) |
Cash and cash equivalents and restricted cash at beginning of the year |
|
|
65,987 |
|
|
|
195,000 |
|
|
|
230,192 |
|
|
|
33,566 |
|
Cash and cash equivalents and restricted cash at end of the year |
|
|
195,000 |
|
|
|
230,192 |
|
|
|
145,720 |
|
|
|
21,248 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Reconciliation in amounts on consolidated balance sheets: |
|
|
|
|
|
|
|
|
|
|
|
|
Cash and cash equivalents |
|
|
73,528 |
|
|
|
102,743 |
|
|
|
15,357 |
|
|
|
2,239 |
|
Restricted cash, non-current |
|
|
121,472 |
|
|
|
127,449 |
|
|
|
130,363 |
|
|
|
19,009 |
|
Total cash and cash equivalents and restricted cash |
|
|
195,000 |
|
|
|
230,192 |
|
|
|
145,720 |
|
|
|
21,248 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Supplemental disclosure of cash flow information: |
|
|
|
|
|
|
|
|
|
|
|
|
Dividends payable offset against receivables from shareholders |
|
|
— |
|
|
|
1,711 |
|
|
|
— |
|
|
|
— |
|
|